Avanos Medical (AVNS)
(Delayed Data from NYSE)
$12.28 USD
+0.42 (3.54%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $12.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVNS 12.28 +0.42(3.54%)
Will AVNS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
New Strong Sell Stocks for July 15th
Other News for AVNS
AVNS forms Directional Movement Crossover Bullish on September 18
Is AVNS primed for downward momentum? Fell Below 20 Day Moving Average shows up after slipping 3.1%
Is AVNS poised for a decline? Shooting Star Candlestick shows up after climbing 0.41%
Avanos (AVNS) Acquires Nexus Medical to Expand Device Portfolio
Avanos Medical Acquires Nexus Medical for Growth